Paeds Vivas · fetal-neonatal-and-perinatal
Congenital anomalies and dysmorphic newborn assessment — branching viva
Viva on recognising the dysmorphic newborn, climbing the diagnostic ladder, the four mechanisms of congenital anomalies, and counselling the family.
On this page
Study tools
Target exams
Stem
You are reviewing a term newborn on the postnatal ward. The baby is hypotonic, with a flat facial profile and bilateral talipes. The parents have noticed that the baby "looks different." The examiner asks you to defend your assessment, your investigation strategy, and your communication. [1]
Examiner: Describe the three clinical movements that frame your assessment of a dysmorphic newborn. [1]
Strong answer: Recognise the anomaly, cluster the findings into a pattern, and refer for genetics with the right test attached. The first move is always to confirm the baby is stable; only then do I complete the head-to-toe examination, document every major and minor finding, take a three-generation family history, and photograph the features before building a diagnostic ladder. [1]
Examiner: The baby has a single palmar crease, a sandal-gap between the toes, and a flat occiput. What is your leading diagnosis? [3]
Strong answer: The pattern points to Down syndrome (Trisomy 21). No single feature is diagnostic, but hypotonia with a flat facial profile, upslanting palpebral fissures, a single palmar crease, and sandal-gap toes together form the recognisable gestalt. I would confirm with a karyotype, which is the targeted first-line test when the phenotype points to a whole-chromosome aneuploidy. [3]
Examiner: Walk me through your genetic test ladder for a dysmorphic newborn whose pattern does not fit a named syndrome. [2]
Strong answer: I start with test pattern points to — karyotype for a clear aneuploidy. When the pattern is unexplained, chromosomal microarray is the first-tier test, because it detects the sub-microscopic copy-number variants a karyotype misses. If the baby is critically ill with a suspected monogenic disorder and the microarray is unrevealing, I escalate to rapid exome or genome sequencing, which shortens time to a molecular diagnosis and can change acute management. [2] [11]
References5ShowHide
- [1]Webber DM Developments in our understanding of the genetic basis of birth defects. Birth Defects Research Part A: Clinical and Molecular Teratology, 2015.PMID 26033863
- [2]Miller DT Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics, 2010.PMID 20466091
- [3]Antonarakis SE Down syndrome. Nature Reviews Disease Primers, 2020.PMID 32029743
- [9]Cooper DM Treatment of idiopathic clubfoot. A thirty-year follow-up note. The Journal of Bone and Joint Surgery American Volume, 1995.PMID 7593056
- [11]Petrikin JE The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill children. NPJ Genomic Medicine, 2018.PMID 29449963